| Dr Gabrielle A Vencel Olson, MD | |
|
101 Willmar Ave Sw, Willmar, MN 56201 | |
| (320) 231-5000 | |
| (320) 231-5067 |
| Full Name | Dr Gabrielle A Vencel Olson |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 28 Years |
| Location | 101 Willmar Ave Sw, Willmar, Minnesota |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306812185 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 40191 (Minnesota) | Primary |
| 207Q00000X | Family Medicine | 7833 (North Dakota) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Rice Hospice Program | Willmar, MN | Hospice |
| Carris Health Llc | Willmar, MN | Hospital |
| Bethesda | Willmar, MN | Nursing home |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Centracare Clinic Southwest Llc | 8426457946 | 141 |
News Archive
Novavax, Inc. announced today that the company has decided to discontinue negotiations in its pursuit of the previously announced collaboration with ROVI Pharmaceuticals to develop Novavax's virus-like-particle (VLP)-based vaccines against influenza in the country of Spain.
A recent study shows that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure. Risk of irregular heartbeat and worsening of symptoms in patients with existing heart disease also seemed to increase, but to a lesser degree.
On Saturday, November 21, 2009 Nashboro Village Family Dental will present our First Annual Super Talent and All-Star Show. Hosted by Lelan Statom, WTVF, NewsChannel 5, this event will benefit Operation Stand Down and one of our patients that is battling chronic childhood cancer.
Frustrated by a maintenance of certification process that doesn't improve patient care, the American Gastroenterological Association this week released a proposed alternate pathway to recertification that is based on established learning theory. It eliminates the high-stakes examination and replaces it with active, adaptive, self-directed learning modules that allow for continuous feedback.
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV (NYSE Euronext: PHARM) today announced that Pharming has begun an international, multicenter, randomized, placebo-controlled Phase IIIb clinical study evaluating the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema.
› Verified 2 days ago
| Entity Name | Carris Health Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1598236408 PECOS PAC ID: 7012274228 Enrollment ID: O20190503001162 |
News Archive
Novavax, Inc. announced today that the company has decided to discontinue negotiations in its pursuit of the previously announced collaboration with ROVI Pharmaceuticals to develop Novavax's virus-like-particle (VLP)-based vaccines against influenza in the country of Spain.
A recent study shows that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure. Risk of irregular heartbeat and worsening of symptoms in patients with existing heart disease also seemed to increase, but to a lesser degree.
On Saturday, November 21, 2009 Nashboro Village Family Dental will present our First Annual Super Talent and All-Star Show. Hosted by Lelan Statom, WTVF, NewsChannel 5, this event will benefit Operation Stand Down and one of our patients that is battling chronic childhood cancer.
Frustrated by a maintenance of certification process that doesn't improve patient care, the American Gastroenterological Association this week released a proposed alternate pathway to recertification that is based on established learning theory. It eliminates the high-stakes examination and replaces it with active, adaptive, self-directed learning modules that allow for continuous feedback.
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV (NYSE Euronext: PHARM) today announced that Pharming has begun an international, multicenter, randomized, placebo-controlled Phase IIIb clinical study evaluating the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema.
› Verified 2 days ago
| Entity Name | Centracare Clinic Southwest Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1174106264 PECOS PAC ID: 8426457946 Enrollment ID: O20210602002802 |
News Archive
Novavax, Inc. announced today that the company has decided to discontinue negotiations in its pursuit of the previously announced collaboration with ROVI Pharmaceuticals to develop Novavax's virus-like-particle (VLP)-based vaccines against influenza in the country of Spain.
A recent study shows that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure. Risk of irregular heartbeat and worsening of symptoms in patients with existing heart disease also seemed to increase, but to a lesser degree.
On Saturday, November 21, 2009 Nashboro Village Family Dental will present our First Annual Super Talent and All-Star Show. Hosted by Lelan Statom, WTVF, NewsChannel 5, this event will benefit Operation Stand Down and one of our patients that is battling chronic childhood cancer.
Frustrated by a maintenance of certification process that doesn't improve patient care, the American Gastroenterological Association this week released a proposed alternate pathway to recertification that is based on established learning theory. It eliminates the high-stakes examination and replaces it with active, adaptive, self-directed learning modules that allow for continuous feedback.
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV (NYSE Euronext: PHARM) today announced that Pharming has begun an international, multicenter, randomized, placebo-controlled Phase IIIb clinical study evaluating the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Gabrielle A Vencel Olson, MD 101 Willmar Ave Sw, Willmar, MN 56201 Ph: (320) 231-5000 | Dr Gabrielle A Vencel Olson, MD 101 Willmar Ave Sw, Willmar, MN 56201 Ph: (320) 231-5000 |
News Archive
Novavax, Inc. announced today that the company has decided to discontinue negotiations in its pursuit of the previously announced collaboration with ROVI Pharmaceuticals to develop Novavax's virus-like-particle (VLP)-based vaccines against influenza in the country of Spain.
A recent study shows that patients given beta-blockers may actually be at increased risk of having an adverse cardiac event during a noncardiac surgical procedure. Risk of irregular heartbeat and worsening of symptoms in patients with existing heart disease also seemed to increase, but to a lesser degree.
On Saturday, November 21, 2009 Nashboro Village Family Dental will present our First Annual Super Talent and All-Star Show. Hosted by Lelan Statom, WTVF, NewsChannel 5, this event will benefit Operation Stand Down and one of our patients that is battling chronic childhood cancer.
Frustrated by a maintenance of certification process that doesn't improve patient care, the American Gastroenterological Association this week released a proposed alternate pathway to recertification that is based on established learning theory. It eliminates the high-stakes examination and replaces it with active, adaptive, self-directed learning modules that allow for continuous feedback.
Specialty biopharmaceutical company Santarus, Inc. and biotech company Pharming Group NV (NYSE Euronext: PHARM) today announced that Pharming has begun an international, multicenter, randomized, placebo-controlled Phase IIIb clinical study evaluating the investigational drug RHUCIN for the treatment of acute attacks of angioedema in patients with Hereditary Angioedema.
› Verified 2 days ago
Lee M Haggenjos, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 2nd St Sw Ste 1, Willmar, MN 56201 Phone: 320-235-7232 | |
Dr. Raymond J Mellema, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 | |
Dr. Robert M Kaiser, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 | |
Maria Jones Loerzel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 2nd St Sw, Suite 1, Willmar, MN 56201 Phone: 320-235-7232 Fax: 320-231-8602 | |
Shelly M Staska, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 101 Willmar Ave Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5026 | |
Rachel L Tollefsrud, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 502 2nd St Sw, Suite 1, Willmar, MN 56201 Phone: 320-235-7232 Fax: 320-231-8609 | |
Dr. William E. Hicks, M. D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 101 Willmar Avenue Sw, Willmar, MN 56201 Phone: 320-231-5000 Fax: 320-231-5067 |